We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $5.01B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+11.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+35.56%
5 Year Est. Return
+47.32%
10 Year Est. Return
+493.31%
AUM
$1.44B
AUM Growth
+$68.4M
Cap. Flow
-$66.6M
Cap. Flow %
-4.63%
Top 10 Hldgs %
32.08%
Holding
123
New
8
Increased
28
Reduced
49
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 25.09%
2 Healthcare 23.99%
3 Industrials 13.95%
4 Materials 7.8%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEOG icon
1
Neogen
NEOG
$2.24B
$56.4M 3.92%
3,032,776
-119,307
-4% -$1.96M
OMCL icon
2
Omnicell
OMCL
$2.09B
$49.5M 3.45%
1,495,907
-55,001
-4% -$1.7M
HSTM icon
3
HealthStream
HSTM
$832M
$48M 3.34%
1,627,845
-56,210
-3% -$1.6M
AAON icon
4
Aaon
AAON
$9.13B
$47.4M 3.3%
3,178,619
-98,391
-3% -$1.31M
TYL icon
5
Tyler Technologies
TYL
$13.1B
$45.8M 3.19%
418,535
-13,037
-3% -$1.38M
HLIO icon
6
Helios Technologies
HLIO
$2.68B
$45.7M 3.18%
1,159,246
-44,944
-4% -$1.75M
DORM icon
7
Dorman Products
DORM
$4.24B
$45.1M 3.14%
934,320
+37,202
+4% +$1.72M
CMD
8
DELISTED
Cantel Medical Corporation
CMD
$44M 3.06%
1,016,161
-41,065
-4% -$1.68M
FLTX
9
DELISTED
Fleetmatics Group PLC
FLTX
$40.1M 2.79%
1,129,138
+79,752
+8% +$2.73M
PRLB icon
10
Protolabs
PRLB
$1.85B
$39.1M 2.72%
581,970
+108,931
+23% +$7.16M
RAVN
11
DELISTED
Raven Industries Inc
RAVN
$39M 2.71%
1,559,288
-103,112
-6% -$2.5M
BCPC
12
Balchem Corp
BCPC
$5.25B
$38.6M 2.69%
579,605
-40,743
-7% -$2.54M
ACIW icon
13
ACI Worldwide
ACIW
$5.9B
$37.7M 2.62%
1,867,681
-59,015
-3% -$1.12M
SPSC icon
14
SPS Commerce
SPSC
$2.41B
$36.8M 2.56%
1,299,158
-28,754
-2% -$823K
EPAY
15
DELISTED
Bottomline Technologies Inc
EPAY
$36.8M 2.56%
1,455,013
+177,424
+14% +$4.57M
CSGP icon
16
CoStar Group
CSGP
$12.2B
$36.1M 2.51%
1,967,940
-117,130
-6% -$1.89M
STMP
17
DELISTED
Stamps.com, Inc.
STMP
$36.1M 2.51%
751,992
-275,710
-27% -$11.5M
BLKB icon
18
Blackbaud
BLKB
$1.49B
$36M 2.5%
831,383
-224,806
-21% -$9.48M
ABCO
19
DELISTED
Advisory Board Co
ABCO
$35.3M 2.45%
720,399
+132,824
+23% +$6.25M
PRO
20
DELISTED
PROS Holdings
PRO
$34.5M 2.4%
1,254,052
-42,808
-3% -$1.13M
SSD icon
21
Simpson Manufacturing
SSD
$7.78B
$34.1M 2.37%
984,584
-31,066
-3% -$1.01M
WHG icon
22
Westwood Holdings Group
WHG
$188M
$32.8M 2.28%
530,177
-29,894
-5% -$1.81M
ALGN icon
23
Align Technology
ALGN
$12.7B
$32.2M 2.24%
576,226
-47,318
-8% -$2.5M
FARO
24
DELISTED
Faro Technologies
FARO
$31.9M 2.22%
509,341
-17,147
-3% -$943K
ADVS
25
DELISTED
Advent Software Inc
ADVS
$30.9M 2.15%
1,007,384
-34,299
-3% -$1.1M

Similar funds

Conestoga Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Conestoga Capital Advisors held 123 positions worth $1.44B, up 5% from $1.37B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Conestoga Capital Advisors withdrew a net $66.6M in Q4 2014, closing 5 positions and reducing 49 holdings. Its most notable exit was Geospace Technologies, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in iShares Russell 2000 Growth ETF worth $1.61M.

  • Conestoga Capital Advisors's largest Q4 2014 buy was iShares Russell 2000 Growth ETF: 11,305 shares worth $1.61M.
  • Conestoga Capital Advisors added most to Vascular Solutions Inc in Q4 2014, an estimated $9.24M increase.
  • Conestoga Capital Advisors's biggest Q4 2014 reduction was Abaxis Inc, cutting an estimated $17.3M.
  • Conestoga Capital Advisors fully exited Geospace Technologies in Q4 2014, selling an estimated $21.4M.
  • Conestoga Capital Advisors's ten largest holdings make up 32% of its $1.44B portfolio in Q4 2014.
  • Conestoga Capital Advisors opened 8 new positions and closed 5 in Q4 2014.
  • Conestoga Capital Advisors's portfolio value rose 5% quarter-over-quarter to $1.44B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2014, filed 12 Jan 2015.